From: Doug Skrecky (oberon@vcn.bc.ca)
Date: Fri Mar 26 1999 - 20:46:27 MST
Citations: 1-3
<1>
Authors
Huang MT. Lou YR. Xie JG. Ma W. Lu YP. Yen P. Zhu BT. Newmark H. Ho
CT.
Institution
Laboratory for Cancer Research, College of Pharmacy, Rutgers, The State
University of New Jersey, Piscataway 08854-8020, USA.
Title
Effect of dietary curcumin and dibenzoylmethane on formation
of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and
lymphomas/leukemias in Sencar mice.
Source
Carcinogenesis. 19(9):1697-700, 1998 Sep.
Abstract
Female Sencar mice (6 weeks old) were administered 1 mg of
7,12-dimethylbenz[a]anthracene (DMBA) by oral gavage once a week for 5 weeks.
At 20 weeks after the first dose of DMBA, 68% of mice developed mammary
tumors (the average 1.08 tumors per mouse) and 45% had lymphomas/leukemias.
Feeding 1% dibenzoylmethane (DBM) in AIN 76A diet, starting
at 2 weeks before the first dose of DMBA and continuing until the end of the
experiment, inhibited both the multiplicity and incidence of DMBA-induced
mammary tumor by 97%. The incidence of lymphomas/leukemias was completely
inhibited by 1% DBM diet. In contrast, feeding 2% curcumin diet had little or
no effect on the incidence of mammary tumors, and the incidence of
lymphomas/leukemias was reduced by 53%.
<2>
Authors
Singletary K. MacDonald C. Iovinelli M. Fisher C. Wallig M.
Institution
Department of Food Science and Human Nutrition, University of Illinois,
Urbana-Champaign, Urbana 61801, USA.
Title
Effect of the beta-diketones diferuloylmethane (curcumin) and
dibenzoylmethane on rat mammary DNA adducts and tumors
induced by 7,12-dimethylbenz[a]anthracene.
Source
Carcinogenesis. 19(6):1039-43, 1998 Jun.
Abstract
Curcumin is a beta-diketone constituent of the spice turmeric that possesses
anticarcinogenic properties in several animal models. The present studies
were conducted in order to identify beta-diketones structurally-related to
curcumin that would be effective dietary blocking agents toward the
initiation stage of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary
carcinogenesis. Of the beta-diketone compounds initially screened for their
capacity to induce quinone-reductase (QR) activity in wild-type Hepa1c1c7
cells and a mutant subclone, curcumin (diferuloylmethane) and
dibenzoylmethane were most effective. However, when added to
semipurified diets fed to female rats, dibenzoylmethane
(1%), but not curcumin (1%), was effective in inhibiting in vivo mammary
DMBA-DNA adduct formation. This inhibitory effect on mammary adduct formation
was associated with a significant increase in liver activities of glutathione
S-transferase, QR and 7-ethoxyresorufin-O-deethylase activities. Female rats
provided diets supplemented with dibenzoylmethane at 0.1,
0.5 and 1.0% for 14 days prior to dosing with DMBA exhibited a significant
decrease in mammary tumor development, compared with controls. However, tumor
development for animals fed diets containing 1.0% curcumin was not different
from that of controls. Therefore, dibenzoylmethane, and
possibly other structurally-related beta-diketones, warrant examination as
breast cancer chemopreventative blocking agents.
<3>
Authors
Berne B. Ros AM.
Institution
Department of Dermatology, University Hospital, Uppsala, Sweden.
Title
7 years experience of photopatch testing with sunscreen allergens in Sweden.
Source
Contact Dermatitis. 38(2):61-4, 1998 Feb.
Abstract
Since 1990 7 sunscreen allergens have been included in the standard
photopatch protocol at 2 Swedish dermatology clinics. 355 consecutive
patients with suspected photosensitivity were tested, and in 28 of these
(7.9%), a total of 42 allergic reactions were found. 80% of the reactions
were of photocontact origin. The most common allergen was benzophenone-3
(Eusolex 4360), with 15 photocontact and 1 contact allergic reactions,
followed by isopropyl dibenzoylmethane (Eusolex 8020) (8
photocontact, 4 contact) and butyl methoxydibenzoylmethane
(Parsol 1789), with 6 photocontact reactions. There were 2 cases of
photocontact allergy to phenylbenzimidazole sulfonic acid (Eusolex 232),
which has not been reported previously. 1 case of contact urticaria from
benzophenone-3 was accidentally found. In addition, 21 + reactions of
doubtful relevance were noted in 14 patients: 16 on irradiated and 5 on
non-irradiated test sites. Among these, irritant and phototoxic reactions may
be included. These results indicate that the inclusion of UV filters in the
standard photopatch protocol is important. Immediate-type testing for
urticaria could also be of value.
This archive was generated by hypermail 2.1.5 : Fri Nov 01 2002 - 15:03:24 MST